Novel biomarker has potential for predicting and treating skin cancer metastasis

Published Date: 30 May 2025

Researchers have identified C5aR1 as a novel biomarker for metastasis risk and poor prognosis in patients with cutaneous squamous cell carcinoma (cSCC), the most common type of metastatic skin cancer.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

J. Craig Venter, Who Won the Race to Sequence the Human Genome, Dies at 79

2.

Enhanced CAR T cell therapy offers new strategy for lymphoma

3.

Researchers find distinct cell receptors with the potential for new treatments.

4.

Novel biomarker has potential for predicting and treating skin cancer metastasis

5.

Analysis of 2021 data shows new cancer diagnoses did not rebound as expected following pandemic


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot